David A. Claremon,Lawrence Wayne Dillard,Chengguo Dong,Yi Fan,Lanqi Jia,Zhijie Liu,Stephen D. Lotesta,Andrew Marcus,Suresh B. Singh,Colin M. Tice,Jing Yuan,Wei Zhao,Yajun Zheng,Linghang Zhuang
申请号：
US14990430
公开号：
US09624217B2
申请日:
2016.01.07
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Provided are novel compounds of Formula (I):pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.
